Ignite Creation Date:
2024-05-06 @ 12:31 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03785249
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2018-12-18
Brief Title:
Phase 12 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
Sponsor:
Mirati Therapeutics Inc
Organization:
Mirati Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-12-18
First Submit QC Date:
December 19 2018
Study First Post Date:
2018-12-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL